Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 2265

1.

Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction.

Moolchan ET, Robinson ML, Ernst M, Cadet JL, Pickworth WB, Heishman SJ, Schroeder JR.

Pediatrics. 2005 Apr;115(4):e407-14.

PMID:
15805342
2.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
3.

Efficacy and safety of an over-the-counter transdermal nicotine patch as an aid for smoking cessation.

Davidson M, Epstein M, Burt R, Schaefer C, Whitworth G, McDonald A.

Arch Fam Med. 1998 Nov-Dec;7(6):569-74.

PMID:
9821833
5.

Smoking reduction treatment with 4-mg nicotine gum: a double-blind, randomized, placebo-controlled study.

Batra A, Klingler K, Landfeldt B, Friederich HM, Westin A, Danielsson T.

Clin Pharmacol Ther. 2005 Dec;78(6):689-96.

PMID:
16338284
6.
7.

Nicotine patch therapy in adolescent smokers.

Smith TA, House RF Jr, Croghan IT, Gauvin TR, Colligan RC, Offord KP, Gomez-Dahl LC, Hurt RD.

Pediatrics. 1996 Oct;98(4 Pt 1):659-67.

PMID:
8885942
8.

Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial.

Shiffman S, Ferguson SG, Strahs KR.

Am J Prev Med. 2009 Feb;36(2):96-104.e1. doi: 10.1016/j.amepre.2008.09.039.

PMID:
19135903
9.

Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial.

Kornitzer M, Boutsen M, Dramaix M, Thijs J, Gustavsson G.

Prev Med. 1995 Jan;24(1):41-7.

PMID:
7740014
10.
11.

Smoking reduction promotes smoking cessation: results from a double blind, randomized, placebo-controlled trial of nicotine gum with 2-year follow-up.

Wennike P, Danielsson T, Landfeldt B, Westin A, T√łnnesen P.

Addiction. 2003 Oct;98(10):1395-402.

PMID:
14519176
12.

Nicotine patch therapy in 101 adolescent smokers: efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levels.

Hurt RD, Croghan GA, Beede SD, Wolter TD, Croghan IT, Patten CA.

Arch Pediatr Adolesc Med. 2000 Jan;154(1):31-7.

PMID:
10632247
14.

Triple-combination pharmacotherapy for medically ill smokers: a randomized trial.

Steinberg MB, Greenhaus S, Schmelzer AC, Bover MT, Foulds J, Hoover DR, Carson JL.

Ann Intern Med. 2009 Apr 7;150(7):447-54.

PMID:
19349630
15.
16.

The transdermal nicotine patch: results of a randomised placebo-controlled trial.

Richmond RL, Harris K, de Almeida Neto A.

Med J Aust. 1994 Jul 18;161(2):130-5.

PMID:
8028537
18.

A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation.

O'Malley SS, Cooney JL, Krishnan-Sarin S, Dubin JA, McKee SA, Cooney NL, Blakeslee A, Meandzija B, Romano-Dahlgard D, Wu R, Makuch R, Jatlow P.

Arch Intern Med. 2006 Mar 27;166(6):667-74.

PMID:
16567607
19.
20.

A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.

Evins AE, Cather C, Culhane MA, Birnbaum A, Horowitz J, Hsieh E, Freudenreich O, Henderson DC, Schoenfeld DA, Rigotti NA, Goff DC.

J Clin Psychopharmacol. 2007 Aug;27(4):380-6.

PMID:
17632223

Supplemental Content

Support Center